22203-98-1O=C(Nc1cccc(Cl)c1)c1cc(Cl)ccc1ONXDGLRGDIKDWIF-UHFFFAOYSA-N22203-98-1DTXSID80176752CHEMBL2088011UsesSARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1].
No reaction records under the current filter.
Loading…